A cloud-based platform for improving cancer treatment with radiation therapy
Cloud/Web-Based Platform for Quantitative SPECT Reconstruction of Therapeutic Radionuclides
This study is creating an online tool that helps doctors give the right amount of radiation for cancer treatment by using advanced imaging, so patients can receive more personalized care based on their specific tumors.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Radiopharmaceutical Imaging and Dosimetry, LLC NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11069459 on NIH RePORTER |
What this research studies
This research focuses on developing a cloud/web-based platform that enhances the quantitative imaging and dosimetry of therapeutic radionuclides used in cancer treatment. By utilizing advanced imaging techniques, the platform aims to provide precise dosimetry, which is crucial for the effective application of radiopharmaceutical therapy (RPT). Patients will benefit from a more personalized approach to their cancer treatment, as the platform will help tailor radiation doses to individual tumor characteristics. The methodology involves integrating data from various imaging sources to improve the accuracy of radiation delivery to cancer cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing or considering radiopharmaceutical therapy.
Not a fit: Patients with non-cancerous conditions or those not eligible for radiopharmaceutical therapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments through improved radiation therapy.
How similar studies have performed: Other research has shown success in using advanced imaging techniques for cancer treatment, indicating that this approach has potential for significant advancements.
Where this research is happening
Baltimore, United States
- Radiopharmaceutical Imaging and Dosimetry, LLC — Baltimore, United States (Active)
Researchers
- Principal investigator: Ghaly, Michael — Radiopharmaceutical Imaging and Dosimetry, LLC
- Study coordinator: Ghaly, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.